These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 33640783

  • 1. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A, Memon A, Razavi SM, Lail NS, Vaughn CB, Mohammadi P, Sawyer RN, Shirani P.
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [Abstract] [Full Text] [Related]

  • 2. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y, Liang L, Smith EE, Schwamm LH, Reeves MJ, Olson DM, Hernandez AF, Fonarow GC, Peterson ED.
    JAMA; 2012 Jun 27; 307(24):2600-8. PubMed ID: 22735429
    [Abstract] [Full Text] [Related]

  • 3. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
    Mazya MV, Lees KR, Markus R, Roine RO, Seet RC, Wahlgren N, Ahmed N, Safe Implementation of Thrombolysis in Stroke Investigators.
    Ann Neurol; 2013 Aug 27; 74(2):266-74. PubMed ID: 23744571
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr 27; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 5. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T, Hanumanthu R, Khandelwal P.
    J Stroke Cerebrovasc Dis; 2019 Nov 27; 28(11):104360. PubMed ID: 31501036
    [Abstract] [Full Text] [Related]

  • 6. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.
    Kamal H, Mehta BK, Ahmed MK, Kavak KS, Zha A, Lail NS, Shirani P, Al-Mufti F, Sawyer RN, Mowla A.
    J Neurol Sci; 2021 Jan 15; 420():117265. PubMed ID: 33333324
    [Abstract] [Full Text] [Related]

  • 7. Sex difference in the association between triglyceride and intracerebral bleeding risk after intravenous thrombolysis for acute ischemic stroke, a multi-center retrospective study.
    Yuan Q, Han Y, Fang S, Lei H, Huang H, Lin H, Wu X, Chen R, Chen Z, Chen J, Li H, Liu N, Du H.
    PeerJ; 2024 Jan 15; 12():e17558. PubMed ID: 38938613
    [Abstract] [Full Text] [Related]

  • 8. Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis.
    Peng TJ, Schwamm LH, Fonarow GC, Hassan AE, Hill M, Messé SR, Coronado F, Falcone GJ, Sharma R.
    JAMA Neurol; 2024 Jul 01; 81(7):722-731. PubMed ID: 38767894
    [Abstract] [Full Text] [Related]

  • 9. Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis.
    Kurowski D, Jonczak K, Shah Q, Yaghi S, Marshall RS, Ahmad H, McKinney J, Torres J, Ishida K, Cucchiara B.
    J Stroke Cerebrovasc Dis; 2017 May 01; 26(5):1104-1109. PubMed ID: 28110890
    [Abstract] [Full Text] [Related]

  • 10. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y, Han Y, Shen H, Wang Y, Ma F, Li H, Wang Y, Dong Q.
    Stroke Vasc Neurol; 2020 Dec 01; 5(4):348-352. PubMed ID: 32611728
    [Abstract] [Full Text] [Related]

  • 11. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC, Masjuan J, Egido JA, Fuentes B, Simal P, Díaz-Otero F, Reig G, Díez-Tejedor E, Gil-Nuñez A, Vivancos J, Alonso de Leciñana M.
    Cerebrovasc Dis; 2012 Dec 01; 33(3):231-9. PubMed ID: 22261670
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
    You S, Saxena A, Wang X, Tan W, Han Q, Cao Y, Liu CF.
    Stroke Vasc Neurol; 2018 Mar 01; 3(1):22-27. PubMed ID: 29600004
    [Abstract] [Full Text] [Related]

  • 13. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov 01; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012 Nov 01; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

  • 15. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy.
    Abbas A, Hamad AA, El Din Moawad MH, Ewis DK, Youssef RA, Hamouda H, Hassan MA, Aladawi M, Elfil M, Meshref M, Al-Mufti F.
    J Stroke Cerebrovasc Dis; 2024 Jul 01; 33(7):107704. PubMed ID: 38561167
    [Abstract] [Full Text] [Related]

  • 16. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S, Tsivgoulis G, Bavarsad Shahripour R, Jones GM, Alexandrov AV, Zand R.
    J Stroke Cerebrovasc Dis; 2015 Dec 01; 24(12):2685-93. PubMed ID: 26542821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.
    Mowla A, Sharifian-Dorche M, Mehla S, Lail NS, Sharifian-Dorche A, Vaughn CB, Sawyer RN, Shirani P.
    J Neurol Sci; 2021 Jun 15; 425():117451. PubMed ID: 33882341
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Significance of Stroke-Associated Infection and other Readily Available Parameters in Acute Ischemic Stroke Treated by Intravenous Thrombolysis.
    Derbisz J, Nowak K, Wnuk M, Pulyk R, Jagiella J, Slowik J, Dziedzic T, Slowik A.
    J Stroke Cerebrovasc Dis; 2021 Feb 15; 30(2):105525. PubMed ID: 33338755
    [Abstract] [Full Text] [Related]

  • 20. Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial.
    Adeoye O, Sucharew H, Khoury J, Vagal A, Schmit PA, Ewing I, Levine SR, Demel S, Eckerle B, Katz B, Kleindorfer D, Stettler B, Woo D, Khatri P, Broderick JP, Pancioli AM.
    Stroke; 2015 Sep 15; 46(9):2529-33. PubMed ID: 26243231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.